摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-hydroxy-flavone

中文名称
——
中文别名
——
英文名称
2-hydroxy-flavone
英文别名
2-hydroxyflavanone;flavanonol;mono-hydroxy flavanone;2-hydroxy-2-phenyl-3H-chromen-4-one
2-hydroxy-flavone化学式
CAS
——
化学式
C15H12O3
mdl
——
分子量
240.258
InChiKey
ABFVFIZSXKRBRL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    黄酮盐酸sodium hydroxide 作用下, 反应 48.0h, 生成 2-hydroxy-flavone
    参考文献:
    名称:
    Zsuga, Miklos; Kiss, Aniko, Acta Chimica Hungarica, 1987, vol. 124, # 3, p. 485 - 490
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
    申请人:Vander Jagt L. David
    公开号:US20060258752A1
    公开(公告)日:2006-11-16
    A method is described for cancer treatment through NFκB inhibition. NFκB is a direct or ultimate target for small molecule inhibitors. These small molecule inhibitors are aimed at suppression of NFκB directly or by indirect suppression of IKK, SFK kinases, or other upstream kinases. The present invention includes small molecule inhibitors comprising three, five, and seven carbon unsaturated spacers having one or two carbonyls, flanked by substituted aryl rings. The small molecule inhibitors can be symmetrical or unsymmetrical.
    描述了一种通过NFκB抑制来治疗癌症的方法。NFκB是小分子抑制剂的直接或最终靶点。这些小分子抑制剂旨在通过直接抑制NFκB或通过间接抑制IKK、SFK激酶或其他上游激酶来抑制NFκB。本发明包括包含三、五和七碳不饱和间隔子的小分子抑制剂,其具有一个或两个羰基,被取代芳基环包围。这些小分子抑制剂可以是对称的或非对称的。
  • USE OF 3-(3-HYDROXY-4-METHOXY-PHENYL)-1-(2,4,6-TRIHYDROXY-PHENYL) PROPAN-1-ONE
    申请人:SYMRISE AG
    公开号:US20190343777A1
    公开(公告)日:2019-11-14
    The present invention concerns the use of 3-(3-Hydroxy-4-methoxy-phenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one for masking, reducing or suppressing an unpleasant taste impression, preferably bitter, sour and/or astringent taste impression of unpleasant-tasting substances or mixture of substances, preferably bitter-, sour-, and/or astringent-tasting substances or mixtures of substances, and in particular the bitter taste impression of bitter-tasting substances, and/or modulating the taste impressions selected from the group consisting of cooling, umami, fruity and spicy notes of cooling-, umami-, fruity- or spicy-tasting substances or mixture of substances, and simultaneously intensifying the sweet-taste impression of sweet-tasting substances or mixtures of substances or both sweet- and bitter-tasting tasting substances or mixture of substances.
    本发明涉及使用3-(3-羟基-4-甲氧基苯基)-1-(2,4,6-三羟基苯基)丙酮来掩盖、减少或抑制令人不愉快的味觉印象,优选是苦、酸和/或涩的不愉快味觉印象的不愉快味道物质或物质混合物,优选是苦味、酸味和/或涩味物质或物质混合物,特别是苦味物质的苦味印象,和/或调节选自冷却、鲜味、果味和辛辣味的味觉印象的味道物质或物质混合物,同时增强甜味物质或物质混合物或甜味和苦味物质或物质混合物的甜味印象。
  • [EN] NEW AZA- TETRACYCLO DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS D'AZA-TÉTRACYCLO
    申请人:CIDQO 2012 S L
    公开号:WO2017182464A1
    公开(公告)日:2017-10-26
    The present invention relates to compounds of formula (I); which are capable of inhibiting the 11-beta-hydroxysteroid dehydrogenase type 1 (11- beta-HSD1), to processes for preparing these compounds, to pharmaceutical compositions comprising an effective amount of these compounds, to the use of the compounds in medicine in particular for the treatment of pathological conditions or diseases that can improve by inhibition of 11-beta-HSD1, to the use of said compound for the manufacture of a medicament for the treatment of pathological conditions or diseases that can improve by inhibition of 11-beta-HSD1 and to methods for the treatment or prevention of a disease or conditions susceptible of improvement by inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11β-HD1) in a subject in need thereof comprising the administration to said subject of a therapeutically effective amount of said compounds.
    本发明涉及式(I)的化合物,该化合物能够抑制11-β-羟基类固醇脱氢酶1型(11-β-HSD1),涉及制备这些化合物的方法,包括这些化合物的有效量的药物组合物,将这些化合物用于医学,特别是用于治疗通过抑制11-β-HSD1可以改善的病理状况或疾病,将所述化合物用于制造用于治疗通过抑制11-β-HSD1可以改善的病理状况或疾病的药物,以及用于治疗或预防需要的受试者中通过抑制11β-羟基类固醇脱氢酶1型(11β-HD1)可以改善的疾病或病症的方法,包括向该受试者施用所述化合物的治疗有效量。
  • [DE] VERWENDUNG VON ALKYLOXYALKANSÄUREAMIDEN INSBESONDERE ALS AROMASTOFFE SOWIE NEUE ALKYLOXYALKANSÄUREAMIDE<br/>[EN] USE OF ALKYLOXYALCANIC ACID AMIDES, IN PARTICULAR IN THE FORM OF AROMATIC SUBSTANCES AND A NOVEL ALKYLOXYALCANIC ACID AMIDE<br/>[FR] UTILISATION D'AMIDES DE L'ACIDE ALKYLOXYALCANIQUE, NOTAMMENT COMME AROMATISANTS, ET NOUVEL AMIDE DE L'ACIDE ALKYLOXYALCANIQUE
    申请人:SYMRISE GMBH & CO KG
    公开号:WO2006003210A1
    公开(公告)日:2006-01-12
    Beschrieben wird die Verwendung bestimmter Alkyloxyalkansäureamide als (i) Aromastoff und/oder (ii) zur Erzeugung eines Gefühls von Kribbeln und/oder (iii) zur Erzeugung eines Gefühls von Schärfe und/oder (iv) zur Anregung des Speichelfusses im Mund und/oder (v) zur Verstärkung des Geschmacks von Ethanol und/oder (vi) zur Imitierung des Geschmacks von Ethanol.
    描述了特定的烷氧基烷基酰胺的用途,作为(i)香料和/或(ii)产生刺痛感和/或(iii)产生辛辣感和/或(iv)刺激口腔中的唾液分泌和/或(v)增强乙醇的味道和/或(vi)模拟乙醇的味道。
  • Catalytic Enantioselective Synthesis of 2-Aryl Chromenes and Related Phosphoramidite Ligands and Catalyst Compounds
    申请人:Northwestern University
    公开号:US20150315168A1
    公开(公告)日:2015-11-05
    Methods to access 2-aryl chromene compounds via an asymmetric catalytic process.
    通过不对称催化过程访问2-芳基色素化合物的方法。
查看更多